International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-1 doi: 10.5281/zenodo.14211968
Original Research Article
Unravelling the Nexus: A Comprehensive Clinicopathological Study of Oral Cancer in A Tertiary Care Centre of Western Odisha
Published
Feb. 4, 2025
Abstract

Cancer of the oral cavity is one of the most common malignancy worldwide. The oral cavity cancer is a major public health problem in the Indian subcontinent, where it ranks among the top three cancer types in both incidence and mortality. The substantial risk factor includes tobacco products, alcohol, poor oral hygiene, nutrition, viral and dentition. There is high prevalence of oral cancer in western Odisha due to rampant use of tobacco. Oral cancer generally refers to squamous cell carcinoma of oral mucosal origin, which accounts for more than 90 percent of all malignancies. Early detection is easy and associated with improvement in survival whereas late detection results in significant morbidity and mortality. Well differentiated carcinomas have minimal pleomorphism and few mitosis. Surgery and radiotherapy being the main modality of treatment. In our study the focus is to determine risk factors associated with oral cancer, to determine the commonest site of presentation, to find out the gender and age group with highest incidence, to find the presenting stage at the time of hospital visit.

Recommended Articles
Loading Image...
Volume-6, Issue-1
Citations
1147 Views
54 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved